{"id":69013,"date":"2026-03-13T11:58:53","date_gmt":"2026-03-13T11:58:53","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69013"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"kpv-lysine-proline-valine","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/kpv-lysine-proline-valine\/","title":{"rendered":"KPV (Lysine-Proline-Valine)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que le KPV ?<\/h3>\n<p style=\"margin: 0;\"><strong>KPV<\/strong> est le tripeptide Lys-Pro-Val \u2014 le fragment C-terminal anti-inflammatoire de l'hormone stimulante des m\u00e9lanocytes alpha (\u03b1-MSH). Contrairement aux analogues plus larges des m\u00e9lanocortines, le KPV n'a <strong>aucune activit\u00e9 de pigmentation<\/strong>; its signal is purely anti-inflammatory via NFkB inhibition and mast-cell stabilization. Studied for IBD, allergic inflammation, and skin-inflammation studies. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">67727-97-3<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>16<\/sub>H<sub>30<\/sub>N<sub>4<\/sub>O<sub>4<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">342.43 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lys-Pro-Val (\u03b1-MSH 11\u201313)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (ou tel que fourni)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138 \u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220 \u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138 \u00b0C, \u00e0 utiliser dans ~30 jours. Prot\u00e9ger de la lumi\u00e8re. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que le KPV ?<\/h2>\n<p><strong>KPV<\/strong> est l'abr\u00e9viation en code \u00e0 trois lettres et une lettre du <strong>tripeptide Lys-Pro-Val<\/strong> \u2014 the C-terminal three amino acids (positions 11\u201313) of alpha-melanocyte stimulating hormone (\u03b1-MSH). In the 1980s\u20131990s, multiple groups noticed that the full \u03b1-MSH molecule produced two functionally separable effects: the well-known N-terminal MC-receptor pigmentation\/arousal activity, and a C-terminal <strong>action anti-inflammatoire<\/strong> activity. When the C-terminal KPV tripeptide was synthesised and tested in isolation, it reproduced the anti-inflammatory effects without the pigmentation side-effects. Molecular weight approximately 342.4\u00a0Da. KPV is one of the smallest peptides in the melanocortin family and one of the most-studied anti-inflammatory studies tripeptides. It is supplied as a high-purity lyophilized powder. For mechanism, IBD studies history, and stacking context, see our <a href=\"https:\/\/medsbase.com\/fr\/kpv-peptide-anti-inflammatory-guide\/\">KPV guide<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Trois voies anti-inflammatoires<\/h2>\n<p>L'activit\u00e9 anti-inflammatoire du KPV agit par au moins trois voies compl\u00e9mentaires, qui convergent toutes vers la r\u00e9duction de la signalisation inflammatoire sans affecter les autres fonctions des m\u00e9lanocortines :<\/p>\n<ul>\n<li><strong>\u2014 Le KPV bloque la translocation de NFkB dans le noyau, emp\u00eachant la transcription des cytokines pro-inflammatoires, notamment le TNF-alpha, l'IL-6, l'IL-1\u03b2 et l'IL-8. NFkB est le r\u00e9gulateur principal de l'expression des g\u00e8nes inflammatoires, donc bloquer son activation produit un effet anti-inflammatoire large et en amont.<\/strong> \u2014 Le KPV bloque la translocation du NFkB vers le noyau, emp\u00eachant ainsi la transcription des cytokines pro-inflammatoires telles que le TNF-alpha, l'IL-6, l'IL-1\u03b2 et l'IL-8. Le NFkB est le r\u00e9gulateur principal de l'expression des g\u00e8nes inflammatoires, donc bloquer son activation produit un large effet anti-inflammatoire en amont.<\/li>\n<li><strong>Mast-cell stabilization<\/strong> \u2014 KPV reduces mast-cell degranulation and histamine release in study models. This is a distinct mechanism from NFkB inhibition and is particularly relevant to allergic-inflammation studies and topical skin-inflammation models.<\/li>\n<li><strong>S\u00e9paration peptide-vs-MSH<\/strong> \u2014 parce que KPV est uniquement le fragment C-terminal, il <strong>n'active pas MC1R<\/strong> (le r\u00e9cepteur de pigmentation) ou MC4R (le r\u00e9cepteur d'\u00e9veil\/alimentation). Cela s\u00e9pare m\u00e9caniquement l'activit\u00e9 anti-inflammatoire des autres effets de l'\u03b1-MSH \u2014 distinct des analogues MC plus larges tels que <a href=\"https:\/\/medsbase.com\/fr\/melanotan-ii\/\">Melanotan II<\/a> ou <a href=\"https:\/\/medsbase.com\/fr\/pt-141\/\">PT-141<\/a>.<\/li>\n<\/ul>\n<p>The practical studies implication: KPV is a &#8220;clean&#8221; anti-inflammatory tool that produces the \u03b1-MSH anti-inflammatory signal without the tanning, arousal, or appetite-modulation effects that complicate interpretation of studies using full-length MC agonists. <\/p>\n<h2>Published Evidence<\/h2>\n<p>KPV is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>IBD and colitis studies<\/strong> \u2014 inflammatory bowel disease rodent models; KPV is active via both SC and oral routes, making it unusually flexible for GI-inflammation studies (Brzoska et al., Endocr Rev 2008)<\/li>\n<li><strong>Inflammation allergique<\/strong> \u2014 mast-cell stabilization and histamine-release studies in allergy and atopy models<\/li>\n<li><strong>Inflammation cutan\u00e9e<\/strong> \u2014 eczema, psoriasis, and contact-dermatitis study models; topical formulations appear in some protocols<\/li>\n<li><strong>Cicatrisation<\/strong> \u2014 anti-inflammatory phase of wound-healing studies, often paired with <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> pour une couverture combin\u00e9e anti-inflammatoire et facteurs de croissance<\/li>\n<li><strong>Inflammation articulaire<\/strong> \u2014 arthritis and joint-inflammation rodent study models<\/li>\n<li><strong>Stacking studies<\/strong> \u2014 souvent associ\u00e9 \u00e0 <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> in GI and connective-tissue studies where anti-inflammatory + tissue-repair coverage is needed<\/li>\n<li><strong>Melanocortin comparative studies<\/strong> \u2014 c\u00f4te \u00e0 c\u00f4te avec <a href=\"https:\/\/medsbase.com\/fr\/melanotan-ii\/\">Melanotan II<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/pt-141\/\">PT-141<\/a> pour isoler les effets purement anti-inflammatoires vs ceux des r\u00e9cepteurs MC<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur les peptides anti-inflammatoires et cicatrisants, voir le <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a>. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase propose le KPV dans les flacons lyophilis\u00e9s suivants :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing \u2014 supports ~10 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 supports ~20 administrations at 500 mcg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>KPV protocols span a range depending on model system \u2014 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies, or topical\/oral routes for GI and skin contexts. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Comparaison \u2014 KPV vs autres peptides anti-inflammatoires \/ m\u00e9lanocortines<\/h2>\n<p>KPV is one of the cleanest anti-inflammatory peptides in use because its activity is so narrow. Compared to related compounds:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">KPV<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Melanotan II<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 acides amin\u00e9s<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 acides amin\u00e9s<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 acides amin\u00e9s (cyclique)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Activit\u00e9 principale<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anti-inflammatoire uniquement<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Anti-inflammatoire + r\u00e9paration tissulaire + r\u00e9cepteur GH<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Agoniste large des r\u00e9cepteurs MC (MC1-5)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Activit\u00e9 sur les r\u00e9cepteurs MC<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucune (extr\u00e9mit\u00e9 C-terminale uniquement)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucun<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MC1, MC3, MC4, MC5<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Effet sur la pigmentation<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucun<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Aucun<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Forte (signal primaire)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Study applications<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">MICI, allergies, inflammation cutan\u00e9e<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tendons, intestin, r\u00e9cup\u00e9ration musculaire<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">M\u00e9lanogen\u00e8se, photoprotection<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For GI-inflammation studies, KPV + BPC-157 is a particularly common combination because KPV provides upstream anti-inflammatory signaling while BPC-157 provides tissue-repair growth-factor activity. This is covered in our <a href=\"https:\/\/medsbase.com\/fr\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. \u00c9viter les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi du flacon de peptide selon le tableau ci-dessus. Agiter doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> secouer \u2014 et laisser 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. La solution doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conserver au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is KPV used for in studies?<\/h3>\n<p>KPV is used in studies investigating anti-inflammatory biology, inflammatory bowel disease (IBD) and colitis, allergic inflammation, skin inflammation (eczema\/psoriasis models), wound-healing inflammation phase, joint inflammation, and comparative melanocortin pharmacology. It is <strong>re\u00e7oit pas<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>En quoi le KPV diff\u00e8re-t-il du Melanotan II ou du PT-141 ?<\/h3>\n<p>Le KPV est uniquement le fragment C-terminal de trois acides amin\u00e9s de l'alpha-MSH, tandis que le Melanotan II et le PT-141 sont des analogues complets ou quasi-complets de la MSH cyclique. Cela signifie que le KPV a <strong>aucune activit\u00e9 sur les r\u00e9cepteurs des m\u00e9lanocortines<\/strong> et donc aucun effet sur la pigmentation (MC1R), l'\u00e9veil (MC4R) ou l'app\u00e9tit (MC4R) \u2014 uniquement une activit\u00e9 anti-inflammatoire via les voies NFkB et des mastocytes. <\/p>\n<h3>What is the typical KPV dose?<\/h3>\n<p>Published preclinical protocols typically use 200\u2013500\u00a0mcg SC daily for systemic anti-inflammatory studies. Some IBD and skin-inflammation uses oral or topical administration. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5\u00a0mg\/mL \u2014 10 ticks on a U-100 SC syringe delivers 500\u00a0mcg. <\/p>\n<h3>Le KPV est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>No. KPV has not received FDA, EMA, or any regulatory approval. The full alpha-MSH peptide and KPV-related has informed melanocortin drug development broadly, but KPV itself remains. All KPV sold by peptide-studies suppliers is for clinical investigation only. <\/p>\n<h3>Can KPV be taken orally for IBD studies?<\/h3>\n<p>Yes. Unlike most peptides which are degraded by gastric enzymes, KPV retains some anti-inflammatory activity via the oral route in published IBD and colitis studies. This makes it unusually flexible for GI-inflammation studies where oral delivery targets the GI tract directly. Study protocols vary by model \u2014 SC remains the dominant systemic route. <\/p>\n<h3>Comment le KPV doit-il \u00eatre stock\u00e9 ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e. <\/p>\n<h3>Comment reconstituer le KPV ?<\/h3>\n<p>Suivez le tableau de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon, agitez doucement et laissez reposer 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas. <\/p>\n<h3>Can KPV and BPC-157 be stacked in studies?<\/h3>\n<p>Yes \u2014 this is one of the most common studies combinations for GI and connective-tissue inflammation. KPV provides upstream NFkB-pathway anti-inflammatory signaling; <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> fournit une activit\u00e9 de r\u00e9paration tissulaire et de facteur de croissance via la voie VEGF. Les m\u00e9canismes sont compl\u00e9mentaires plut\u00f4t que superpos\u00e9s. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase propose le KPV en flacons lyophilis\u00e9s de 5 mg et 10 mg. Chaque dosage est disponible en lots de 10, 20 ou 30 flacons. Tous les flacons sont fournis avec une puret\u00e9 HPLC de 99 %+ et un certificat d'analyse sur demande. <\/p>\n<h3>Does KPV cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile. Because KPV has no melanocortin-receptor activity, the pigmentation, arousal, and blood-pressure effects sometimes seen with full MC agonists do not occur with KPV. No significant off-target signals have been identified at typical doses. Long-term human safety data are not available. <\/p>\n<h3>Quelle est la demi-vie du KPV ?<\/h3>\n<p>KPV (Lys-Pro-Val) is a tripeptide with a short plasma half-life consistent with small unmodified peptides \u2014 estimated at under 30 minutes. Its primary application is gastrointestinal, where local delivery studies show effects on gut epithelial cells and immune cell populations that persist beyond plasma detection, attributed to direct receptor interaction at the intestinal mucosa. <\/p>\n<h3>How does KPV reduce inflammation in study models?<\/h3>\n<p>KPV est le tripeptide C-terminal de l'\u03b1-MSH (hormone stimulante des m\u00e9lanocytes alpha) et conserve une grande partie de l'activit\u00e9 anti-inflammatoire du peptide parent via l'activation du MC1R. Dans les mod\u00e8les de colite et de l\u00e9sion intestinale, KPV r\u00e9duit la signalisation NF-\u03baB, diminue la production de cytokines pro-inflammatoires (IL-1\u03b2, IL-6, TNF-\u03b1) et favorise l'int\u00e9grit\u00e9 de la barri\u00e8re \u00e9pith\u00e9liale intestinale. Sa petite taille facilite son absorption directe par les cellules \u00e9pith\u00e9liales sans d\u00e9pendre de prot\u00e9ines porteuses. <\/p>\n<h3>Puis-je commander du KPV pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le KPV dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 \u00e0 l'exp\u00e9dition de peptides. Les commandes contenant uniquement des peptides sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition d\u00e9di\u00e9 aux peptides. Les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/fr\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/fr\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agoniste s\u00e9lectif de la ghr\u00e9line \u2014 pic d'hormone de croissance propre sans cortisol\/prolactine<\/li>\n<li><a href=\"\/fr\/cjc-1295-with-dac\/\"><strong>CJC-1295 avec DAC<\/strong><\/a> \u2014 Analogue de GHRH avec demi-vie prolong\u00e9e<\/li>\n<li><a href=\"\/fr\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lisez notre guide complet bas\u00e9 sur des preuves : <a href=\"https:\/\/medsbase.com\/fr\/kpv-peptide-anti-inflammatory-guide\/\"><strong>KPV \u2014 the C-terminal alpha-MSH fragment for anti-inflammatory studies<\/strong><\/a>. Covers NFkB pharmacology, mast-cell stabilization, IBD studies history, oral and SC protocols, and stacking with BPC-157.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorise la r\u00e9paration tissulaire<br \/>\n\u2705 R\u00e9duit le stress oxydatif<br \/>\n\u2705 Module la r\u00e9ponse immunitaire<br \/>\n\u2705 Renforce la r\u00e9silience cellulaire<br \/>\n\u2705 Am\u00e9liore l'int\u00e9grit\u00e9 \u00e9pith\u00e9liale<\/p>\n<p><strong>KPV<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70964,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5472,5473],"class_list":["post-69013","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-kpv","product_tag-lysine-proline-valine","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/69013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=69013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70964"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=69013"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=69013"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=69013"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=69013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}